-
Product Insights
NewNet Present Value Model: Moleculin Biotech Inc’s Annamycin
Empower your strategies with our Net Present Value Model: Moleculin Biotech Inc's Annamycin report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Angiosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Angiosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Angiosarcoma Drug Details: L-Annamycin is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Liposarcoma Drug Details: L-Annamycin is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STAR-0602 in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STAR-0602 in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STAR-0602 in Oropharyngeal Cancer Drug Details: STAR-0602 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Relapsed Acute Myeloid Leukemia Drug Details: L-Annamycin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Refractory Acute Myeloid Leukemia Drug Details: L-Annamycin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Synovial Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Synovial Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Synovial Sarcoma Drug Details: L-Annamycin is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Annamycin in Soft Tissue Sarcoma Drug Details: L-Annamycin is under...
-
Product Insights
NewRecurrent Malignant Glioma – Drugs In Development, 2024
Empower your strategies with our Recurrent Malignant Glioma  – Drugs In Development, 2024 report and make more profitable business decisions. Recurrent malignant glioma is defined as the recurrence of a glioma tumor after treatment. Symptoms include chest pain due to a tumor located in the chest area of the spinal cord, erectile dysfunction, lack of ability to feel changes in temperature, loss of muscle control, loss of bowel or bladder control, numbness or tingling, pain in the arm, neck, back,...
-
Product Insights
NewPleomorphic Liposarcoma – Drugs In Development, 2024
Empower your strategies with our Pleomorphic Liposarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Pleomorphic liposarcoma is a rare and aggressive subtype of liposarcoma, a malignant tumor that arises from fat cells. Unlike other liposarcomas, pleomorphic liposarcoma is characterized by its pleomorphic, or varied and irregular, appearance under the microscope. This subtype often occurs in the deep soft tissues of the limbs and the retroperitoneum. Pleomorphic liposarcoma tends to be more challenging to treat than other...